Leidos (NYSE: LDOS) will build an initial 3,000 Low-Cost Containerized Munitions under a new Department of War framework agreement announced on Wednesday, a move aimed at rapidly increasing missile stockpiles.
The agreements send “a clear, long-term demand signal to innovative new entrants,” said Michael Duffey, under secretary of defense for acquisition and sustainment, in a statement seen by Reuters.
The Pentagon also entered into framework agreements with Anduril, CoAspire, and Zone 5 to establish the Low‑Cost Containerized Munitions (LCCM) program. Leidos's stock currently has a consensus Wall Street price target of $175.59, implying a 36.8% upside, with 50% of analysts rating it a Buy, according to data from 24/7 Wall St.
The program signals a strategic shift by the Pentagon to expand its industrial base beyond traditional prime contractors. The assessment phase will begin with test missile purchases from all four companies in June 2026, aiming to deploy large quantities of missiles from standard shipping containers.
The framework establishes the terms for future firm-fixed-price production contracts, though a specific cost was not disclosed. The initiative is part of a broader push by the U.S. military to find lower-cost, mobile ways to deploy weapons systems and increase its munitions inventory amid global conflicts.
The contract award reinforces the bullish outlook for Leidos, which 24/7 Wall St. rates as a "BUY." Their model projects a potential 12-month high of $200.44 for the stock in an optimistic scenario, driven by factors like better-than-expected earnings and favorable sector conditions.
This agreement provides a significant revenue pipeline for Leidos and solidifies its position within the Pentagon's evolving defense industrial strategy. Investors will now watch for the results of the test phase beginning in June 2026 for further signs of the program's long-term scale.
This article is for informational purposes only and does not constitute investment advice.
